gadolinium dtpa has been researched along with Hormone-Dependent Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahri, S; Butler, JA; Carpenter, PM; Chen, JH; Feig, SA; Hsiang, DJ; Kuzucan, A; Lane, KT; Lin, M; Mehta, RS; Nalcioglu, O; Su, MY; Yu, HJ | 1 |
1 other study(ies) available for gadolinium dtpa and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carboplatin; Contrast Media; Cyclophosphamide; Doxorubicin; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Ki-67 Antigen; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Neoplasms, Hormone-Dependent; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Trastuzumab; Treatment Outcome | 2011 |